Form 8-K - Current report:
SEC Accession No. 0001193125-18-037978
Filing Date
2018-02-09
Accepted
2018-02-09 16:10:33
Documents
7
Period of Report
2018-02-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d508699d8k.htm 8-K 24357
2 EX-1.1 d508699dex11.htm EX-1.1 229615
3 EX-5.1 d508699dex51.htm EX-5.1 7408
4 EX-99.1 d508699dex991.htm EX-99.1 12152
5 GRAPHIC g508699page043.jpg GRAPHIC 21908
6 GRAPHIC g508699page044.jpg GRAPHIC 21908
7 GRAPHIC g508699page045.jpg GRAPHIC 21151
  Complete submission text file 0001193125-18-037978.txt   364526
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 18591816
SIC: 8071 Services-Medical Laboratories